For the Inventor, By the Inventor

Enter assignee name

Ontario, Canada

Syn X Pharma, Inc.

USPTO Granted Patents = 33

% Expired Patents = 87.9

EPO Patents = 1

Forward Citations = 308

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

George Jackowski (32 out of 71 patents)

John G Marshall (26 out of 44 patents)

Jason Yantha (16 out of 27 patents)

4. Brad Thatcher (16 out of 22 patents)

5. Tammy Vrees (16 out of 21 patents)

6. Miyoko Takahashi (3 out of 9 patents)

7. Rulin Zhang (1 out of 2 patents)

8. Shirley Furesz (1 out of 1 patent)

9. Weimin Zhu (1 out of 2 patents)

10. Christopher Smith (1 out of 1 patent)

11. Eric B Stanton (1 out of 5 patents)

12. Michelle Davey (3 patents)

13. Peter Kupchak (3 patents)

33 patents: Sort by Forward Citations

1. 7179606 - IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease (2007-02-20),

2. 7132244 - Betaine/GABA transport protein biopolymer marker indicative of insulin resistance (2006-11-07),

3. 7101680 - Method for detecting the presence of monomeric brain associated human glutamine synthetase (2006-09-05),

4. 7097989 - Complement C3 precursor biopolymer markers predictive of type II diabetes (2006-08-29),

5. 7094549 - Fibronectin biopolymer marker indicative of insulin resistance (2006-08-22),

6. 7087435 - Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons (2006-08-08),

7. 7074576 - Protein biopolymer markers indicative of alzheimer's disease (2006-07-11),

8. 7070945 - Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment (2006-07-04),

9. 7052849 - Protein biopolymer markers predictive of insulin resistance (2006-05-30),

10. 7049397 - Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons (2006-05-23),

11. 7026129 - IG lambda biopolymer markers predictive of Alzheimers disease (2006-04-11),

12. 7015004 - Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance (2006-03-21),

13. 7014854 - Method for retarding or precluding Alzheimer's dementia (2006-03-21),

14. 6998243 - Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons (2006-02-14),

15. 6891154 - Amino acid sequence pattern matching (2005-05-10),

Syn X Pharma, Inc. is a global pharmaceutical company dedicated to providing innovative healthcare solutions. Our team of experts works tirelessly to discover, develop, and deliver high-quality medicines to improve the lives of people worldwide. With a focus on research and development, Syn X Pharma is committed to addressing unmet medical needs and advancing healthcare standards.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

33 Patents

#5 in Ontario

#10,288 in Canada

#20,112 in the World

Ontario, Canada

Syn X Pharma, Inc.

Forward Citations = 308

11 inventors:

George Jackowski (32 out of 71 patents)

John G Marshall (26 out of 44 patents)

Jason Yantha (16 out of 27 patents)

4. Brad Thatcher (16 out of 22 patents)

5. Tammy Vrees (16 out of 21 patents)

Please report any incorrect information to [email protected]

Loading…